The TGM2_v2 spliced variant generated a short form of TG2 (TG2-S or TGH; 548 amino acids) first discovered in human erythroleukemia cells [63] and reported to be increased in brain tissue of Alzheimer’s disease patients [64]. This evidence concerns the gene TGM2 and early-onset autosomal dominant Alzheimer disease.